Resveratrol Regulates Glucose and Lipid Metabolism in Diabetic Rats by Inhibition of PDK1/AKT Phosphorylation and HIF-1α Expression

References

• James DE, Stockli J, Birnbaum MJ. The aetiology and molecular landscape of insulin resistance. Nat Rev Mol Cell Biol. 2021;22(11):751–771. doi:10.1038/s41580-021-00390-6
   PubMed Web of Science ®Google Scholar
• Cheng Z, Qiao D, Zhao S, Zhang B, Lin Q, Xie F. Whole grain rice: updated understanding of starch digestibility and the regulation of glucose and lipid metabolism. Compr Rev Food Sci Food Saf. 2022;21(4):3244–3273. doi:10.1111/1541-4337.12985
   PubMed Web of Science ®Google Scholar
• Li KX, Ji MJ, Sun HJ. An updated pharmacological insight of resveratrol in the treatment of diabetic nephropathy. Gene. 2021;780:145532. doi:10.1016/j.gene.2021.145532
   PubMed Web of Science ®Google Scholar
• Miao R, Fang X, Wei J, et al. Target for Metabolic Syndrome. Front Physiol. 2022;13:822333. doi:10.3389/fphys.2022.822333
   PubMed Web of Science ®Google Scholar
• Di Blasio L, Gagliardi PA, Puliafito A, Primo L. Serine/Threonine Kinase 3-Phosphoinositide-Dependent Protein Kinase-1 (PDK1) as a key regulator of cell migration and cancer dissemination. Cancers. 2017;9(3):25. doi:10.3390/cancers9030025
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ, Xie C, Jiang C. The role of hypoxia-inducible factors in metabolic diseases. Nat Rev Endocrinol. 2018;15(1):21–32. doi:10.1038/s41574-018-0096-z
   PubMed Web of Science ®Google Scholar
• LaGory EL, Giaccia AJ. The ever-expanding role of HIF in tumour and stromal biology. Nat Cell Biol. 2016;18(4):356–365. doi:10.1038/ncb3330
   PubMed Web of Science ®Google Scholar
• Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol. 2001;21(12):3995–4004. doi:10.1128/MCB.21.12.3995-4004.2001
   PubMed Web of Science ®Google Scholar
• Lee YS, Kim JW, Osborne O, et al. Increased adipocyte O2 consumption triggers HIF-1alpha, causing inflammation and insulin resistance in obesity. Cell. 2014;157(6):1339–1352. doi:10.1016/j.cell.2014.05.012
   PubMed Web of Science ®Google Scholar
• Mesarwi OA, Moya EA, Zhen X, et al. Hepatocyte HIF-1 and intermittent hypoxia independently impact liver fibrosis in murine nonalcoholic fatty liver disease. Am J Respir Cell Mol Biol. 2021;65(4):390–402. doi:10.1165/rcmb.2020-0492OC
   PubMed Web of Science ®Google Scholar
• Dodd MS, Sousa Fialho MDL, Montes Aparicio CN, et al. Fatty acids prevent hypoxia-inducible factor-1alpha signaling through decreased succinate in diabetes. JACC Basic Transl Sci. 2018;3(4):485–498. doi:10.1016/j.jacbts.2018.04.005
   PubMedGoogle Scholar
• Halberg N, Khan T, Trujillo ME, et al. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol. 2009;29(16):4467–4483. doi:10.1128/MCB.00192-09
   PubMed Web of Science ®Google Scholar
• Ochiai D, Goda N, Hishiki T, et al. Disruption of HIF-1alpha in hepatocytes impairs glucose metabolism in diet-induced obesity mice. Biochem Biophys Res Commun. 2011;415(3):445–449. doi:10.1016/j.bbrc.2011.10.089
   PubMed Web of Science ®Google Scholar
• Jardim FR, de Rossi FT, Nascimento MX, et al. Resveratrol and brain mitochondria: a review. Mol Neurobiol. 2018;55(3):2085–2101. doi:10.1007/s12035-017-0448-z
   PubMed Web of Science ®Google Scholar
• Bhatt JK, Thomas S, Nanjan MJ. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res. 2012;32(7):537–541. doi:10.1016/j.nutres.2012.06.003
   PubMed Web of Science ®Google Scholar
• Ding S, Jiang J, Wang Z, et al. Resveratrol reduces the inflammatory response in adipose tissue and improves adipose insulin signaling in high-fat diet-fed mice. PeerJ. 2018;6:e5173. doi:10.7717/peerj.5173
   PubMed Web of Science ®Google Scholar
• Wang XL, Wu LY, Zhao L, et al. SIRT1 activator ameliorates the renal tubular injury induced by hyperglycemia in vivo and in vitro via inhibiting apoptosis. Bio Pharm. 2016;83:41–50. doi:10.1016/j.biopha.2016.06.009
   Google Scholar
• Wang X, Meng L, Zhao L, et al. Resveratrol ameliorates hyperglycemia-induced renal tubular oxidative stress damage via modulating the SIRT1/FOXO3a pathway. Diabetes Res Clin Pract. 2017;126:172–181. doi:10.1016/j.diabres.2016.12.005
   PubMed Web of Science ®Google Scholar
• Gheibi S, Kashfi K, Ghasemi A. A practical guide for induction of type-2 diabetes in rat: incorporating a high-fat diet and streptozotocin. Bio Pharm. 2017;95:605–613. doi:10.1016/j.biopha.2017.08.098
   Google Scholar
• Den Hartogh DJ, Tsiani E. Health benefits of resveratrol in kidney disease: evidence from in vitro and in vivo studies. Nutrients. 2019;11(7):1624. doi:10.3390/nu11071624
   PubMed Web of Science ®Google Scholar
• Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27–31. doi:10.4103/0976-0105.177703
   PubMedGoogle Scholar
• Di Angelantonio E, Sarwar N, Perry PL, et al.; Emerging Risk Factors C. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993–2000. doi:10.1001/jama.2009.1619
   PubMed Web of Science ®Google Scholar
• Zhao L, Chen Y, Tang R, et al. Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis. J Gastroenterol Hepatol. 2011;26(5):875–883. doi:10.1111/j.1440-1746.2010.06560.x
   PubMed Web of Science ®Google Scholar
• Barcat D, Amadio A, Palos-Pinto A, et al. Combined hyperlipidemia/hyperalphalipoproteinemia associated with premature spontaneous atherosclerosis in mice lacking hepatic lipase and low density lipoprotein receptor. Atherosclerosis. 2006;188(2):347–355. doi:10.1016/j.atherosclerosis.2005.11.022
   PubMed Web of Science ®Google Scholar
• Giammanco A, Noto D, Barbagallo CM, et al. Hyperalphalipoproteinemia and Beyond: the role of HDL in cardiovascular diseases. Life. 2021;11(6):581. doi:10.3390/life11060581
   PubMedGoogle Scholar
• Catrina SB, Zheng X. Hypoxia and hypoxia-inducible factors in diabetes and its complications. Diabetologia. 2021;64(4):709–716. doi:10.1007/s00125-021-05380-z
   PubMed Web of Science ®Google Scholar
• Girgis CM, Cheng K, Scott CH, Gunton JE. Novel links between HIFs, type 2 diabetes, and metabolic syndrome. Trends Endocrinol Metab. 2012;23(8):372–380. doi:10.1016/j.tem.2012.05.003
   PubMed Web of Science ®Google Scholar
• Botusan IR, Sunkari VG, Savu O, et al. Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci U S A. 2008;105(49):19426–19431. doi:10.1073/pnas.0805230105
   PubMed Web of Science ®Google Scholar
• Cheng K, Ho K, Stokes R, et al. Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets. J Clin Invest. 2010;120(6):2171–2183. doi:10.1172/JCI35846
   PubMed Web of Science ®Google Scholar
• Gu HF, Zheng X, Abu Seman N, et al. Impact of the hypoxia-inducible factor-1 alpha (HIF1A) Pro582Ser polymorphism on diabetes nephropathy. Diabetes Care. 2013;36(2):415–421. doi:10.2337/dc12-1125
   PubMed Web of Science ®Google Scholar
• Michailidou Z, Morton NM, Moreno Navarrete JM, et al. Adipocyte pseudohypoxia suppresses lipolysis and facilitates benign adipose tissue expansion. Diabetes. 2015;64(3):733–745. doi:10.2337/db14-0233
   PubMed Web of Science ®Google Scholar
• Rahtu-Korpela L, Karsikas S, Horkko S, et al. HIF prolyl 4-hydroxylase-2 inhibition improves glucose and lipid metabolism and protects against obesity and metabolic dysfunction. Diabetes. 2014;63(10):3324–3333. doi:10.2337/db14-0472
   PubMed Web of Science ®Google Scholar
• Li X, Li J, Wang L, et al. The role of metformin and resveratrol in the prevention of hypoxia-inducible factor 1alpha accumulation and fibrosis in hypoxic adipose tissue. Br J Pharmacol. 2016;173(12):2001–2015. doi:10.1111/bph.13493
   PubMed Web of Science ®Google Scholar
• Ma Z, Zhang Y, Li Q, Xu M, Bai J, Wu S. Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1alpha expression and mitochondrial ROS production. PLoS One. 2017;12(8):e0183426. doi:10.1371/journal.pone.0183426
   PubMed Web of Science ®Google Scholar
• Sha W, Liu M, Sun D, et al. Resveratrol ameliorated endothelial injury of thoracic aorta in diabetic mice and Gly-LDL-induced HUVECs through inhibiting TLR4/HIF-1alpha. J Cell Mol Med. 2021;25(13):6258–6270. doi:10.1111/jcmm.16584
   PubMed Web of Science ®Google Scholar
• Lebeau PF, Byun JH, Platko K, et al. Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearance. Nat Commun. 2022;13(1):770. doi:10.1038/s41467-022-28240-9
   PubMed Web of Science ®Google Scholar
• Kucejova B, Sunny NE, Nguyen AD, et al. Uncoupling hypoxia signaling from oxygen sensing in the liver results in hypoketotic hypoglycemic death. Oncogene. 2011;30(18):2147–2160. doi:10.1038/onc.2010.587
   PubMed Web of Science ®Google Scholar
• Wang XL, Suzuki R, Lee K, et al. Ablation of ARNT/HIF1beta in liver alters gluconeogenesis, lipogenic gene expression, and serum ketones. Cell Metab. 2009;9(5):428–439. doi:10.1016/j.cmet.2009.04.001
   PubMed Web of Science ®Google Scholar
• Pez F, Dayan F, Durivault J, et al. The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth. Cancer Res. 2011;71(5):1647–1657. doi:10.1158/0008-5472.CAN-10-1516
   PubMed Web of Science ®Google Scholar
• Vasudevan KM, Garraway LA. AKT signaling in physiology and disease. Curr Top Microbiol Immunol. 2010;347:105–133. doi:10.1007/82_2010_66
   PubMed Web of Science ®Google Scholar
• Brito PM, Devillard R, Negre-Salvayre A, et al. Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells. Atherosclerosis. 2009;205(1):126–134. doi:10.1016/j.atherosclerosis.2008.11.011
   PubMed Web of Science ®Google Scholar
• Xu F, Wang Y, Cui W, et al. Resveratrol prevention of diabetic nephropathy is associated with the suppression of renal inflammation and mesangial cell proliferation: possible roles of Akt/NF-kappaB pathway. Int J Endocrinol. 2014;2014:289327. doi:10.1155/2014/289327
   PubMed Web of Science ®Google Scholar
• Taha C, Liu Z, Jin J, Al-Hasani H, Sonenberg N, Klip A. Opposite translational control of GLUT1 and GLUT4 glucose transporter mRNAs in response to insulin. Role of mammalian target of rapamycin, protein kinase b, and phosphatidylinositol 3-kinase in GLUT1 mRNA translation. J Biol Chem. 1999;274(46):33085–33091. doi:10.1074/jbc.274.46.33085
   PubMed Web of Science ®Google Scholar
• Zelzer E, Levy Y, Kahana C, Shilo BZ, Rubinstein M, Cohen B. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J. 1998;17(17):5085–5094. doi:10.1093/emboj/17.17.5085
   PubMed Web of Science ®Google Scholar
• Li RL, He LY, Zhang Q, et al. HIF-1alpha is a potential molecular target for herbal medicine to treat diseases. Drug Des Devel Ther. 2020;14:4915–4949. doi:10.2147/DDDT.S274980
   PubMed Web of Science ®Google Scholar
• Naito K, Kanki K. Glycolytic inhibition by resveratrol prevents myoblast cell death caused by glucose deprivation and hypoxia; a possible application to the three-dimensional tissue construction. J Biosci Bioeng. 2021;131(1):90–97. doi:10.1016/j.jbiosc.2020.08.010
   PubMed Web of Science ®Google Scholar
• Chandra NC. A comprehensive account of insulin and LDL receptor activity over the years: a highlight on their signaling and functional role. J Biochem Mol Toxicol. 2021;35(9):e22840. doi:10.1002/jbt.22840
   PubMed Web of Science ®Google Scholar
• Jing Y, Hu T, Lin C, et al. Resveratrol downregulates PCSK9 expression and attenuates steatosis through estrogen receptor alpha-mediated pathway in L02cells. Eur J Pharmacol. 2019;855:216–226. doi:10.1016/j.ejphar.2019.05.019
   PubMed Web of Science ®Google Scholar
• Hwang S, Nguyen AD, Jo Y, Engelking LJ, Brugarolas J, DeBose-Boyd RA. Hypoxia-inducible factor 1alpha activates insulin-induced gene 2 (Insig-2) transcription for degradation of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase in the liver. J Biol Chem. 2017;292(22):9382–9393. doi:10.1074/jbc.M117.788562
   PubMed Web of Science ®Google Scholar
• Bjune K, Wierod L, Naderi S. Inhibitors of AKT kinase increase LDL receptor mRNA expression by two different mechanisms. PLoS One. 2019;14(6):e0218537. doi:10.1371/journal.pone.0218537
   PubMed Web of Science ®Google Scholar
• He Y, Yang W, Gan L, et al. Silencing HIF-1alpha aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-alpha/ANGPTL4 singling pathway. Gastroenterol Hepatol. 2021;44(5):355–365. doi:10.1016/j.gastrohep.2020.09.014
   PubMed Web of Science ®Google Scholar